Consolidated Statements of Cash Flows
(in thousands)
For the six months ended | ||||||||
December 30, 2018 | December 31, 2017 | |||||||
Cash flows from operating activities: | ||||||||
Net loss | $ | (5,239 | ) | $ | (7,876 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | 5,468 | 5,051 | ||||||
Share-based compensation expense | 199 | 397 | ||||||
Loss on sale of asset | 34 | — | ||||||
Loss on sale of subsidiaries | — | 109 | ||||||
Bad debt expense and other | 59 | 84 | ||||||
Changes in working capital: | ||||||||
Accounts receivable | 986 | (137 | ) | |||||
Inventory | (2,706 | ) | (138 | ) | ||||
Prepaid expenses and other assets | 1,897 | 609 | ||||||
Accounts payable | (227 | ) | 1,486 | |||||
Accrued expenses and other current liabilities | (18 | ) | (1,472 | ) | ||||
Deferred revenue | (265 | ) | 222 | |||||
Net cash provided by (used in) operating activities | 188 | (1,665 | ) | |||||
Cash flows from investing activities: | ||||||||
Purchases of property and equipment | (760 | ) | (1,500 | ) | ||||
Proceeds from sale of subsidiary | — | 3,000 | ||||||
Net cash (used in) provided by investing activities | (760 | ) | 1,500 | |||||
Cash flows from financing activities: | ||||||||
Proceeds from debt issuance | 38,417 | 49,533 | ||||||
Repayments of long-term debt and capital lease obligations | (37,858 | ) | (50,040 | ) | ||||
Issuance of common stock under employee stock purchase plan and exercise of stock options | — | 155 | ||||||
Net cash provided by (used in) financing activities | 559 | (352 | ) | |||||
Effect of exchange rates on cash | (103 | ) | 311 | |||||
Net decrease in cash | (116 | ) | (206 | ) | ||||
Cash, beginning of period | 365 | 593 | ||||||
Cash, end of period | $ | 249 | $ | 387 | ||||
Supplemental disclosures of cash flow information: | ||||||||
Cash paid for interest | $ | 1,052 | $ | 1,244 | ||||
Cash paid for income taxes, net of refunds | $ | 87 | $ | 48 |